[go: up one dir, main page]

TW259713B - - Google Patents

Info

Publication number
TW259713B
TW259713B TW081110315A TW81110315A TW259713B TW 259713 B TW259713 B TW 259713B TW 081110315 A TW081110315 A TW 081110315A TW 81110315 A TW81110315 A TW 81110315A TW 259713 B TW259713 B TW 259713B
Authority
TW
Taiwan
Prior art keywords
sugar
solid preparation
withstand
buccal cavity
strength
Prior art date
Application number
TW081110315A
Other languages
English (en)
Original Assignee
Yamanouchi Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharma Co Ltd filed Critical Yamanouchi Pharma Co Ltd
Application granted granted Critical
Publication of TW259713B publication Critical patent/TW259713B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
TW081110315A 1991-12-24 1992-12-23 TW259713B (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP35689891 1991-12-24
JP33507692 1992-11-20

Publications (1)

Publication Number Publication Date
TW259713B true TW259713B (zh) 1995-10-11

Family

ID=26575054

Family Applications (1)

Application Number Title Priority Date Filing Date
TW081110315A TW259713B (zh) 1991-12-24 1992-12-23

Country Status (15)

Country Link
US (1) US5466464A (zh)
EP (1) EP0651997B1 (zh)
JP (1) JP2807346B2 (zh)
KR (1) KR100256147B1 (zh)
AT (1) ATE172637T1 (zh)
AU (1) AU666509B2 (zh)
CA (1) CA2126669C (zh)
DE (1) DE69227467T2 (zh)
FI (1) FI943042L (zh)
HU (1) HU219349B (zh)
NO (1) NO307404B1 (zh)
NZ (1) NZ246091A (zh)
RU (1) RU2109509C1 (zh)
TW (1) TW259713B (zh)
WO (1) WO1993012769A1 (zh)

Families Citing this family (84)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5744500A (en) * 1990-01-03 1998-04-28 Teva Pharmaceutical Industries, Ltd. Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof
JP3069458B2 (ja) * 1992-01-29 2000-07-24 武田薬品工業株式会社 口腔内崩壊型錠剤およびその製造法
US5457895A (en) * 1993-10-01 1995-10-17 R. P. Scherer Corporation Method of identifying freeze-dried dosage forms
US5837287A (en) * 1994-10-28 1998-11-17 R P Scherer Corporation Process for preparing solid pharmaceutical dosage forms
US5738875A (en) * 1994-10-28 1998-04-14 R.P. Scherer Corporation Process for preparing solid pharmaceutical dosage forms
TR199700878T1 (xx) † 1995-03-02 1998-01-21 R.P. Scherer Limited Monamin oksidaz B inhibit�rleri i�eren farmakotik kompozisyonlar.
GB9517062D0 (en) * 1995-08-18 1995-10-25 Scherer Ltd R P Pharmaceutical compositions
PT893992E (pt) * 1996-04-16 2004-06-30 Novartis Consumer Health Sa Formas de dosagem oral de desintegracao rapida
JP3797387B2 (ja) 1996-06-14 2006-07-19 協和醗酵工業株式会社 口腔内速崩壊錠
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
ATE342735T1 (de) 1997-03-28 2006-11-15 Eisai Co Ltd Orale pharmazeutische zusammensetzungen mit reduzierter bitterkeit durch geschmacksmaskiermittel
WO1999017754A1 (en) * 1997-10-08 1999-04-15 Sepracor Inc. Dosage form for aerosol administration
TW527195B (en) 1997-10-09 2003-04-11 Ssp Co Ltd Fast-soluble solid pharmaceutical combinations
US6413541B1 (en) 1999-01-13 2002-07-02 Dainippon Pharmaceutical Co., Ltd. Disintegrating tablet in oral cavity and production thereof
GB9802088D0 (en) * 1998-01-30 1998-03-25 Scherer Ltd R P Pharmaceutical products
US6589554B1 (en) 1998-03-16 2003-07-08 Yamanouchi Pharmaceutical Co., Ltd. Tablets quickly disintegrating in the oral cavity and process for producing the same
EP1025858A4 (en) * 1998-08-28 2009-03-11 Eisai R&D Man Co Ltd DRUGS WITH REDUCED BITTERNESS ETC.
WO2000020033A1 (fr) 1998-10-05 2000-04-13 Eisai Co., Ltd. Comprimes se delitant immediatement dans la cavite buccale
US6552024B1 (en) 1999-01-21 2003-04-22 Lavipharm Laboratories Inc. Compositions and methods for mucosal delivery
US6680071B1 (en) 1999-03-03 2004-01-20 R. P. Scherer Technologies, Inc. Opioid agonist in a fast dispersing dosage form
GB9908014D0 (en) 1999-04-08 1999-06-02 Scherer Corp R P Pharmaceutical compositions
GB9910505D0 (en) 1999-05-06 1999-07-07 Electrosols Ltd A method and apparatus for manufacturing consumable tablets
AU765526B2 (en) * 1999-08-17 2003-09-18 Novartis Consumer Health S.A. Rapidly dissolving dosage form and process for making same
ES2327898T3 (es) * 2000-03-01 2009-11-05 EISAI R&D MANAGEMENT CO., LTD. Comprimido de desintegracion rapida que contiene poli(alcohol vinilico).
AU2001267865A1 (en) 2000-06-30 2002-01-14 Yamanouchi Pharmaceutical Co..Ltd. Tablet rapidly disintegrating in mouth and process for producing the same
NZ524124A (en) * 2000-08-18 2004-09-24 Pharmacia Corp Rapidly disintegrating oral formulation of a cyclooxygenase-2 inhibitor
DE10041479A1 (de) 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung zur Verabreichung von N-0923
WO2002032403A1 (en) * 2000-10-16 2002-04-25 Daiichi Pharmaceutical Co., Ltd. Medicinal compositions quickly disintegrating in the oral cavity and process for producing the same
US6544557B2 (en) 2001-01-09 2003-04-08 Pan Pharmaceutical Limited Effervescent tablet compositions
US6588180B2 (en) 2001-02-02 2003-07-08 R. P. Scherer Technologies, Inc. Constricted neck blister pack and apparatus and method for making the same
JP2004520389A (ja) * 2001-02-08 2004-07-08 ファルマシア・コーポレーション 性的不全の治療のための早期効果発現薬剤
WO2002069934A1 (fr) * 2001-03-06 2002-09-12 Kyowa Hakko Kogyo Co., Ltd. Préparations se délitant rapidement dans la bouche
US20040131673A1 (en) * 2001-03-22 2004-07-08 Coffee Ronald Alan Manufacturing dissolvable dosage forms
US6509040B1 (en) 2001-06-22 2003-01-21 R.P. Scherer Corporation Fast dispersing dosage forms essentially free of mammalian gelatin
US7255876B2 (en) * 2001-07-27 2007-08-14 Astellas Pharma, Inc. Composition comprises sustained-release fine particles and manufacturing method thereof
US8017657B1 (en) * 2001-09-07 2011-09-13 Advanced Medical Instruments Composition for the treatment and prevention of endothelial dysfunction
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
CA2476250C (en) 2002-02-13 2010-08-03 Michael K. Weibel Drug dose-form and method of manufacture
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
US20030017208A1 (en) * 2002-07-19 2003-01-23 Francis Ignatious Electrospun pharmaceutical compositions
MXPA05003512A (es) * 2002-10-04 2005-06-03 Pharmacia Corp Composiciones y metodos para el tratamiento de la disfuncion sexual.
FI20022007A0 (fi) * 2002-11-08 2002-11-08 Juvantia Pharma Ltd Oy Oromukosaalinen valmiste ja menetelmä sen valmistamiseksi
GB0226076D0 (en) 2002-11-08 2002-12-18 Rp Scherer Technologies Inc Improved formulations containing substituted imidazole derivatives
CN1738600A (zh) * 2002-11-12 2006-02-22 特瓦制药工业有限公司 用于口腔给药和舌下给药的替扎尼定药物组合物及剂型以及舌下或口腔给予替扎尼定的方法
US8367111B2 (en) 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
US20050137265A1 (en) * 2003-03-31 2005-06-23 Haley Eugene T. Rapidly dissolving metoclopramide solid oral dosage and method thereof
US20050036977A1 (en) * 2003-08-11 2005-02-17 Dilip Gole Taste-masked resinate and preparation thereof
KR101159617B1 (ko) * 2003-10-15 2012-06-27 후지카가쿠고교가부시키가이샤 구강내 속붕해성 정제
DE20321887U1 (de) 2003-11-10 2012-01-20 Allergan, Inc. Arzneimittel umfassend niedrige Dosierungen von Desmopressin
CA2545194C (en) 2003-11-10 2014-10-21 Seymour H. Fein Pharmaceutical compositions including low dosages of desmopressin
PT1530967E (pt) * 2003-11-13 2006-09-29 Ferring Bv Embalagem blister e uma forma de dosagem solida que compreende desmopressina.
JP4547161B2 (ja) * 2004-01-22 2010-09-22 エスエス製薬株式会社 用時溶解型速溶性固形製剤
US8545881B2 (en) * 2004-04-19 2013-10-01 Eurand Pharmaceuticals, Ltd. Orally disintegrating tablets and methods of manufacture
US8747895B2 (en) 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
EP1802285B1 (en) 2004-10-21 2013-02-27 Aptalis Pharmatech, Inc. Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
ITMI20042356A1 (it) * 2004-12-10 2005-03-10 Acraf Composizione farmaceutica orodisperdibile e procedimento per prepararla
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
AU2006275405A1 (en) * 2005-08-01 2007-02-08 Teva Pharmaceutical Industries Ltd. Tizanidine compositions and methods of treatment using the compositions
GB0516604D0 (en) * 2005-08-12 2005-09-21 Sandoz Ag Rapidly dispersing/disintegrating compositions
GB2430364A (en) * 2005-09-22 2007-03-28 Carl Ernest Alexander Soft agar bolus for oral drug delivery
EP1897543A1 (en) 2006-08-30 2008-03-12 Euro-Celtique S.A. Buprenorphine- wafer for drug substitution therapy
CN101516367A (zh) 2006-09-15 2009-08-26 安斯泰来制药有限公司 对光稳定的雷莫司琼的固态医药组合物
ES2302650B1 (es) 2007-01-11 2009-02-16 Tedec-Meiji Farma, S.A. Composicion de rapida desintegracion en la cavidad bucal.
JP2010518086A (ja) 2007-02-09 2010-05-27 デュレクト コーポレーション スフェンタニルおよびナロキソンを含む経口腔投与製剤
CA2680536A1 (en) 2007-03-13 2008-10-09 Dainippon Sumitomo Pharma Co., Ltd. Oral disintegrating tablet
US20080260823A1 (en) * 2007-04-20 2008-10-23 Sciele Pharma, Inc. Orally disintegrating tablet comprising glycopyrrolate for treating sialorrhea
US8445044B2 (en) * 2007-05-07 2013-05-21 Kent Precision Foods Group, Inc. Food thickening agent, method for producing food thickening agent
CN101686942B (zh) 2007-06-27 2012-09-26 韩美药品株式会社 用于快速制备用于口服的崩解剂的方法及其产品
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
PT3225250T (pt) 2008-05-21 2019-10-15 Ferring Bv Desmopressina orodispersivel para aumentar o periodo inicial de sono não perturbado pela nocturia
KR101075556B1 (ko) 2008-11-21 2011-10-20 씨제이제일제당 (주) 구강내 속붕해정 및 그 제조방법
EP2506836B1 (en) 2009-12-02 2018-02-14 Adare Pharmaceuticals S.R.L. Fexofenadine microcapsules and compositions containing them
MX365568B (es) 2010-12-02 2019-06-07 Adare Pharmaceuticals Inc Granulos de dispersion rapida, comprimidos de disolucion oral y metodos.
CA2834212C (en) 2011-04-29 2019-05-14 Massachusetts Institute Of Technology Layer processing for pharmaceuticals
JP5365949B2 (ja) * 2011-10-28 2013-12-11 アステラス製薬株式会社 低用量ラモセトロン含有口腔内崩壊錠
WO2014038593A2 (ja) 2012-09-05 2014-03-13 テイカ製薬株式会社 口腔内速崩壊性錠剤用造粒物
JP2013028647A (ja) * 2012-11-06 2013-02-07 Rohto Pharmaceutical Co Ltd 苦味を有する薬物を含有する口中溶解型又は咀嚼型固形内服医薬組成物
US9101156B2 (en) 2013-03-15 2015-08-11 Kent Precision Foods Group, Inc. Thickener composition, thickened nutritive products, methods for preparing thickened nutritive products, and methods for providing nutrition
WO2015063602A1 (en) 2013-10-29 2015-05-07 Ferring B.V. Desmopressin and blood glucose
US10213960B2 (en) 2014-05-20 2019-02-26 Massachusetts Institute Of Technology Plasticity induced bonding
TWI771287B (zh) 2016-02-16 2022-07-21 日商帝化製藥股份有限公司 口腔內速崩壞性錠劑用造粒物
US11751594B2 (en) 2020-10-22 2023-09-12 Grain Processing Corporation Food thickener composition and method

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3419657A (en) * 1964-06-23 1968-12-31 Dagra Nv Iodopanoic acid in a hydrogel
DE1959275A1 (de) * 1969-11-26 1971-05-27 Walter Dr Med Kanis Paste gegen Mundgeruch
IE45770B1 (en) 1976-10-06 1982-11-17 Wyeth John & Brother Ltd Pharmaceutical dosage forms
GB2009597B (en) * 1977-12-10 1982-06-23 Beecham Group Ltd Antacid compositions
US5288497A (en) * 1985-05-01 1994-02-22 The University Of Utah Compositions of oral dissolvable medicaments
US4814178A (en) * 1987-07-01 1989-03-21 Sanford Bolton Floating sustained release therapeutic compositions
DE3744009A1 (de) * 1987-12-24 1989-07-06 Fresenius Ag Geschmacksneutrale, eine oder mehrere aminosaeuren enthaltende pharmazeutische zubereitung
DE68906461T2 (de) 1988-06-07 1993-10-21 Abbott Lab Feste Arzneidosis in Form eines Tablettentriturats sowie Verfahren zu deren Herstellung.
US5288479A (en) * 1989-01-17 1994-02-22 Sterling Drug, Inc. Extrudable elastic oral pharmaceutical gel compositions and metered dose dispensers containing them and method of making and method of use thereof
FR2647343B1 (fr) 1989-05-24 1994-05-06 Rhone Poulenc Sante Nouvelle forme pharmaceutique poreuse et sa preparation
US5079018A (en) * 1989-08-14 1992-01-07 Neophore Technologies, Inc. Freeze dry composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs
US5013557A (en) * 1989-10-03 1991-05-07 Warner-Lambert Company Taste masking compositions comprising spray dried microcapsules containing sucralfate and methods for preparing same

Also Published As

Publication number Publication date
EP0651997A1 (en) 1995-05-10
EP0651997A4 (en) 1995-03-02
NZ246091A (en) 1995-08-28
AU666509B2 (en) 1996-02-15
DE69227467D1 (de) 1998-12-03
HU9401896D0 (en) 1994-09-28
CA2126669A1 (en) 1993-07-08
RU2109509C1 (ru) 1998-04-27
NO942403D0 (zh) 1994-06-23
FI943042A0 (fi) 1994-06-23
AU3095992A (en) 1993-07-28
NO942403L (no) 1994-08-24
KR100256147B1 (ko) 2000-08-01
HUT75455A (en) 1997-05-28
HU219349B (en) 2001-03-28
EP0651997B1 (en) 1998-10-28
DE69227467T2 (de) 1999-04-22
RU94031158A (ru) 1996-04-27
ATE172637T1 (de) 1998-11-15
NO307404B1 (no) 2000-04-03
JP2807346B2 (ja) 1998-10-08
WO1993012769A1 (fr) 1993-07-08
CA2126669C (en) 2002-08-27
FI943042L (fi) 1994-06-23
US5466464A (en) 1995-11-14

Similar Documents

Publication Publication Date Title
TW259713B (zh)
MY129552A (en) Solid oral dosage form comprising a combination of metformin and glibenclamide
AU7848187A (en) Pharmaceutical formulations
EP0627218A4 (en) QUICK-RELEASE TABLET.
CA2061917A1 (en) Pediatric effervescent dosage form
IE812232L (en) Composition
CA2002363A1 (en) Sustained release preparations
AU4297089A (en) Dispersable formulation of diclofenac in free acid form
PT615754E (pt) Formas solidas de administracao oral de libertacao controlada flupertina
HU9202375D0 (en) Method for preparing medical preparatives with didesoxi-purine nucleosid content
EA199900102A1 (ru) Таблетка малеата тримебутина, покрытая оболочкой
CA2052901A1 (en) Pharmacologically enhanced formulations
CA2139790A1 (en) Tablets with thioctic acid of specific grain size
CA2074580A1 (en) Solid pharmaceutical composition for oral administration containing dapiprazole
USD293699S (en) Toy play scene
Ellsworth et al. Tolerance to two different forms of oral erythromycin.
Rolin et al. Bactericidal activity of cefotaxime and cefixime in a kinetic model in vitro.
GB2213062A (en) Pharmaceutical preparation having oestrogen action
TH23378A (th) " รูปยาตามขนาดแบบควบคุมการปลดปล่อยของเอซิโธรไมซิน "
JPH01134500U (zh)
DE69325531D1 (de) Oral anzuwendendes Arzneimittel bestehend aus Ibuprofen

Legal Events

Date Code Title Description
MK4A Expiration of patent term of an invention patent